Cargando…
Degradable emulsion as vaccine adjuvant reshapes antigen-specific immunity and thereby ameliorates vaccine efficacy
This study describes the feasibility and adjuvant mechanism of a degradable emulsion for tuning adaptive immune responses to a vaccine antigen. We featured a mouse model with ovalbumin (OVA) as the antigen to deepen our understanding of the properties of a degradable emulsion-based adjuvant, dubbed...
Autores principales: | Huang, Chung-Hsiung, Huang, Chiung-Yi, Cheng, Chih-Ping, Dai, Shih-Hsiung, Chen, Hsin-Wei, Leng, Chih-Hsiang, Chong, Pele, Liu, Shih-Jen, Huang, Ming-Hsi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101498/ https://www.ncbi.nlm.nih.gov/pubmed/27827451 http://dx.doi.org/10.1038/srep36732 |
Ejemplares similares
-
Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice
por: Chiang, Chen-Yi, et al.
Publicado: (2016) -
Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates
por: Liu, Shih-Jen, et al.
Publicado: (2006) -
A Purified Recombinant Lipopeptide as Adjuvant for Cancer Immunotherapy
por: Song, Ying-Chyi, et al.
Publicado: (2014) -
Recombinant lipoprotein-based vaccine candidates against C. difficile infections
por: Huang, Jui-Hsin, et al.
Publicado: (2015) -
Immunogenicity Studies of Bivalent Inactivated Virions of EV71/CVA16 Formulated with Submicron Emulsion Systems
por: Lin, Chih-Wei, et al.
Publicado: (2014)